| abstract |
"USE OF 3,7-DIAZABICYCLE ยข 3.3.1! NONANO COMPOUNDS FOR THE TREATMENT AND / OR PROPHILAXY OF ARRHYMIC EPISODES IN HUMAN MALE SEX PATIENTS". The present invention relates to the use of 3,7 diazabicyclo [3,3,1] nonane compounds, preferably 9.9 alkylene-3,7-diazabicyclo [3.3.1] nonane compounds, and preferably Most preferred is the use of tedisamil, and its physiologically acceptable acidic addition salts and / or solvates, for the treatment and / or prophylaxis of antiarrhythmic episodes in male human patients, preferably in the conversion of atrial fibrillation. (Afib) or newly established atrial flutter at normal sinus rhythm (NSR) in human male patients. |